• ABC News story on lung cancer screening trial "an amazingly unbalanced report"

    Updated: 2011-06-30 15:22:48
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org ABC News story on lung cancer screening trial an amazingly unbalanced report By Gary Schwitzer on June 30, 2011 10:22 AM No Comments No TrackBacks It's been another challenging week for journalists covering various screening stories . First the new analysis of Swedish mammography studies . Some familiar flaws surfaced in some stories Then came the followup analysis of the National Lung Screening Trial first reported last fall . This week various headlines announced : More evidence CT scans better at detecting lung cancer Study bolsters evidence that screening reduces lung cancer deaths Nat'l Study Shows Long-Term Smokers Should Get Lung Cancer CT Scan Most but not that last

  • FDA Panel Rejects Avastin for Breast Cancer

    Updated: 2011-06-30 05:35:53
    Health News FDA Panel Rejects Avastin for Breast Cancer Print E-mail WEDNESDAY , June 29 HealthDay News The blockbuster cancer drug Avastin got soundly rejected late Wednesday as a treatment for metastatic breast cancer by a U.S . health advisory panel that found the medication was not effective and causes dangerous side effects . By unanimous vote , the panelists rejected the drug maker's appeal of a U.S . Food and Drug Administration recommendation last December to revoke Avastin's approval for breast cancer . The FDA recommendation cited the medication's poor performance in follow-up studies and its potential for serious side . effects The drug maker , Genentech , now owned by pharmaceutical giant Roche , was given an unusual two-day hearing this week before the six-member advisory .

  • More Evidence CT Scans Better at Detecting Lung Cancer

    Updated: 2011-06-30 05:35:52
    Health News More Evidence CT Scans Better at Detecting Lung Cancer Print E-mail WEDNESDAY , June 29 HealthDay News Routinely screening longtime smokers and former heavy smokers for lung cancer using CT scans can cut the death rate by 20 percent compared to those screened by chest X-ray , according to a major U.S . government . study The National Lung Screening Trial included more than 53,000 current and former heavy smokers aged 55 to 74 who were randomly chosen to undergo either a low-dose helical CT scan or a chest X-ray once a year for three . years Those results , which showed that those who got the CT scans were 20 percent less likely to die than those who received X-rays alone , were initially published in the journal Radiology in November 2010. The new study , published online July

  • Gene Map' of Ovarian Cancer Yields New Clues to Treatment

    Updated: 2011-06-30 05:35:51
    Health News Gene Map' of Ovarian Cancer Yields New Clues to Treatment Print E-mail WEDNESDAY , June 29 HealthDay News In the largest such study of any tumor type to date , scientists say they've gleaned an in-depth look at genes that may help drive aggressive ovarian . cancer The achievement , which could lead to a better understanding of this silent killer and ways to treat it , comes as part of The Cancer Genome Atlas TCGA Research Network . That project was launched in 2006 by the U.S . National Cancer Institute and the U.S . National Human Genome Research . Institute We have now a map that is telling the cancer research community where to look and what to work on in the future , explained study lead author Paul T . Spellman , who conducted his research while a staff scientist at the

  • Dendreon Receives Approval for Their New Plant in California

    Updated: 2011-06-30 04:04:37
    Early this evening Dendreon received the nod from the FDA to use their new manufacturing plant in Seal Beach, California. The approval of this plant will allow the company to now service the men with advanced prostate cancer in Hawaii as well as more efficiently service those in Western United States with Provenge. When coupling [...]

  • Study shows benefits of motivational text messages for smoking cessation

    Updated: 2011-06-29 21:38:00
    Smokers who receive motivational text messages are twice as likely to quit successfully as those who do not, UK scientists have found.

  • Rocker Gregg Allman "works with" Merck on hepatitis C pitch

    Updated: 2011-06-29 18:22:36
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org Rocker Gregg Allman works with Merck on hepatitis C pitch By Gary Schwitzer on June 29, 2011 1:22 PM No Comments No TrackBacks Physician-blogger Elaine Schattner writes that Gregg of the Allman Brothers has hepatitis C and has teamed with or is working with Merck to promote hep C awareness . She blogs The ethics of this are com­pli­cated : On the one hand , it might be a good thing for a music icon to raise public awareness about hepatitis C , so that more people at risk might get tested and then treated early before they develop severe liver disease and cancer , and would feel better . Gregg Allman is in a position to spread that message effec­tively : If I have hep C , you

  • Malecare Responds to the New York Times About the High Costs of Advanced Prostate Cancer Treatments

    Updated: 2011-06-29 14:18:27
    Darryl, the Malecare Executive Director, posted an organizational response to yesterday’s New York Times Article on the newly approved advanced prostate cancer drugs and their economic impact. I thought that I would share his insightful post with everyone. “We can easily price commodities and drugs to whatever the market will bare, but how do we [...]

  • Ten minute talk boosts breast cancer awareness

    Updated: 2011-06-29 09:00:00
    Educating women about breast cancer increases their knowledge about the disease should they develop a symptom - and could help increase survival from breast cancer, new research today shows.

  • Certain Cancer Drugs Don't Interfere With Flu Vaccine Study

    Updated: 2011-06-29 06:09:23
    : Health News Certain Cancer Drugs Don't Interfere With Flu Vaccine : Study Print E-mail TUESDAY , June 28 HealthDay News Cancer patients taking the drugs sunitinib and sorafenib respond to the flu vaccine , which suggests that the drugs don't cause as much damage to the immune system as previously believed , researchers . say The small study included 40 volunteers in the Netherlands , including 16 who were treated with sunitinib and six who were treated with sorafenib . Seven patients with metastatic renal cell kidney cancer received neither drug , nor did 11 healthy . people When given a flu vaccine , all of the cancer patients had an antibody response similar to that of the healthy . participants The study appears in the current issue of the journal Clinical Cancer Research The exact

  • Research spend on cancer doubles within a decade and the most fatal cancers see investment

    Updated: 2011-06-29 00:01:00
    Partners of the National Cancer Research Institute (NCRI) spent more than £500m on cancer research last year, nearly double the amount spent almost ten years ago, according to new figures.

  • Clash between data and emotion in FDA decision on Avastin for metastatic breast cancer

    Updated: 2011-06-28 21:44:40
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org Clash between data and emotion in FDA decision on Avastin for metastatic breast cancer By Gary Schwitzer on June 28, 2011 4:44 PM No Comments No TrackBacks Dr . Len Lichtenfeld of the American Cancer Society , who drew raves on Twitter today for tweeting from the FDA meeting about whether Avastin should be allowed for the treatment of metastatic breast cancer , also blogged about his day's experience As one might expect , the experience ran the gamut from deeply felt emotions to cold hard . statistics Clearly , we are in a place where emotion meets science and the FDA's decision will prove to be a difficult one . Ultimately , we hope the FDA will make the best decision

  • "Harm has been done" - spine journal's critical review of Medtronic Infuse studies

    Updated: 2011-06-28 20:45:47
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org Harm has been done spine journal's critical review of Medtronic Infuse studies By Gary Schwitzer on June 28, 2011 3:45 PM No Comments No TrackBacks The Spine Journal has published a special June issue focusing on Medtronic's INFUSE product , or rhBMP-2, a bone growth product commonly used in spine fusion surgeries . A journal news release states : A critical review of 13 industry-sponsored studies on a spine surgery product found that the actual risk of adverse events was 10 to 50 times the estimates originally reported . The product in question is recombinant bone morphogenetic protein-2 rhBMP-2 a controversial synthetic bone growth factor often used as a bone graft

  • The High Cost of Prostate Cancer Treatments – How Telling Are the Comments

    Updated: 2011-06-28 17:18:30
    Today’s New York Times carried a front page article about the high cost of the new prostate cancer treatments. This article seems to be the talk of the town and the talk (based on the comments that have been entered on-line) has been anything but positive. Unfortunately, many of the comments have made with the [...]

  • AARP magazine: 4 Surgeries to Avoid

    Updated: 2011-06-28 14:26:01
    : Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org AARP magazine : 4 Surgeries to Avoid By Gary Schwitzer on June 28, 2011 9:26 AM No Comments No TrackBacks The July August issue of AARP magazine features a column on Reasons to think twice before going under the knife . The column's preamble : states The following four operations are overperformed for a variety of reasons : Some are moneymakers for hospitals and doctors , others are expedient , and still others seem to work , at least in the short term . But evidence shows that all have questionable long-term outcomes for treating certain conditions , and some may even cause harm . The four they list are : 1. stents for stable angina 2. complex spinal fusion for stenosis

  • On The Horizon – Xgeva (denosumab) To Prevent or Slow Down Bone Mets

    Updated: 2011-06-28 05:08:22
    Yesterday, Amgen announced that it had submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand its license for XGEVA® (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases. If approved, XGEVA would be the first therapy licensed to prevent or [...]

  • Tell the World About Malecare and Improve Our Exposure

    Updated: 2011-06-27 22:02:55
    Dear Friends, If you love the work of Malecare Cancer Support, then tell the world! You may or may not realize it, but Malecare has grown to become America’s largest men’s cancer survivor support and advocacy national nonprofit. Malecare is a 13-year-old all volunteer organization, and our mission is to help men and their families [...]

  • A Note from Chuck- An Expansion of Naval Vessels with Agent Orange Exposure Making VA Benefits Available to Additional Men

    Updated: 2011-06-27 21:23:56
    The Naval Fleet Reserve Association recently provided the following information regarding updates of the Veterans Administration list of vessels exposed to Agent Orange during the Vietnam conflict. This will include many more veterans eligible for VA care for the many diseases attributed to this product. New Updates VA List of Vessels Exposed to Agent Orange [...]

  • Blocking key cell component could make 'smart drugs' effective for many cancer patients

    Updated: 2011-06-26 18:00:00
    Cancer Research UK scientists at Newcastle University and researchers based at Harvard University have found that blocking a key component of the DNA repair process could extend the use of a new range of 'smart' cancer drugs called PARP inhibitors. The research is published in Nature Medicine today.

  • Study Finds that Degarelix is Superior to Leuprolide

    Updated: 2011-06-24 17:16:51
    According to findings from a long term study, men with prostate cancer (PCa) who are treated with degarelix (a newly approved gonadotropin-releasing hormone receptor (GnRH) blocker) have a lower risk of PSA failure or death compared with those treated with leuprolide. The study included men with advanced PCa who previously had completed a pivotal one-year [...]

  • Some oestrogen-negative breast cancer patients may benefit from prostate cancer therapy

    Updated: 2011-06-24 15:01:00
    Cancer Research UK scientists have discovered why a sub group of oestrogen-receptor-negative breast cancer patients could benefit from prostate cancer treatments which target the cell's androgen receptor - a key driver of prostate cancer, according to research published in The EMBO Journal.

  • Kegel Exercises: A Tutorial

    Updated: 2011-06-24 14:16:49
    Kegel Exercises are not just for women! Kegels are also great for prostate cancer patients because they help minimize incontinence and can ameliorate erectile issues. No related posts.

  • Prevent Prostate Cancer By Sex

    Updated: 2011-06-24 12:59:27
    Many people keep asking whether sex can really help to prevent prostate cancer. This article looks into it and examines how and why sex can help in the prevention of prostate cancer or not. It’s somewhat true that sex can help in the prevention of this condition. It’s really simple, if you look at it [...]

  • FDA Okays 6-Month Dose of Prostate Cancer Drug

    Updated: 2011-06-23 19:00:00
    WASHINGTON -- The FDA has approved a six-month formulation of the prostate cancer drug leuprolide acetate for depot suspension (Lupron Depot).

  • FDA: 5-Alpha-Reductase Inhibitors May Increase High-Grade Prostate Cancer Risk

    Updated: 2011-06-23 15:57:12
    There is a constant debate between both oncologist and advocates about the value and safety of 5-alpha-reductase inhibitors (Proscar and Avodart) both in the early treatment and later treatment of men with prostate cancer. In fact, I have had an on-going private debate with one very knowledgeable educator advocate over this issue. I often have [...]

  • Natural Tips to Prevent Prostate Cancer

    Updated: 2011-06-22 05:27:54
    Prostate cancer is the most common type of cancer among men, with over 200,000 cases diagnosed each year in the United States. It occurs when cells in the prostate, a gland located under the bladder that is necessary for proper sexual function in men, becomes cancerous due to a flux in testosterone. Most cases of [...]

  • Smoking Tied to Worse Prostate Ca Survival

    Updated: 2011-06-21 21:54:49
    Men who are smokers when they receive a prostate cancer diagnosis have significantly worse survival and a greater risk of biochemical recurrence than never-smokers or those who had quit, researchers found.

  • ASCO 2011: Phase II Cabozantinib Trial in Patients with Advanced Solid Tumors and Bone Metastases

    Updated: 2011-06-21 19:52:57
    Data from the recent ASCO conference on a phase II study of cabozantinib (XL184) in patients with advanced solid tumors, including prostate cancer, demonstrates that the investigational treatment has activity in both bone and soft tissue. This study evaluated the efficacy and safety of cabozantinib compared to placebo in 9 different solid tumor types including [...]

  • My Friend Fred

    Updated: 2011-06-21 17:07:15
    My very dear friend Fred who is a 20+ year prostate cancer warrior recorded this video. He has been on chemotherapy this past year. Fred is an activist who has been fighting on behalf of all of us. Thank you, Fred. I just thought I would share his video at: See my friend Fred Joel [...]

  • Gone to London & European Health Journalism conference - Site on hold for a week

    Updated: 2011-06-20 17:14:04
    For the first time in more than 5 years, we won't publish anything this week. I'm off to London and then to Coventry, site of a European health journalism conference. Details here and in the flyer below.

  • Current UK system of Barrett's oesophagus monitoring 'not cost effective'

    Updated: 2011-06-20 15:31:00
    The current system to diagnose and monitor Barrett's oesophagus in the UK may not be as effective as it could be, according to a new study at Queens University Belfast.

  • Completely new approach to cancer vaccines proves succesful in early studies

    Updated: 2011-06-19 18:00:00
    CANCER RESEARCH UK scientists at the University of Leeds have used a library of DNA to create a vaccine that could be used to treat cancer, according to a study published in Nature Medicine.

  • Lab Notes: Next Green Lantern May Wield Jellyfish

    Updated: 2011-06-17 21:59:43
    In Green Lantern's next incarnation, he may generate his power from jellyfish protein instead of a ring, assuming the living lasers featured in this installment of Lab Notes pan out.

  • Life Lessons Re-Learned: Fighting Cancer with the Bobblehead Dad: CNCA Guest Blog

    Updated: 2011-06-17 21:45:00
    : : About Us Sponsored : by CTCA Cancer News U.S . Cancer Patients Face Barriers to Care , Study Finds Even with health insurance , Americans may have trouble booking an oncology appointment Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition

  • 'Too soon to say' whether low carb diet can prevent cancer or slow tumour growth

    Updated: 2011-06-17 17:15:00
    Cancer Research UK has responded to claims that eating a low-carbohydrate, high-protein diet could be beneficial to prevent cancer and slow its growth, by warning that the research is still at a preliminary stage.

  • Deprivation leads to over 2,600 deaths a year

    Updated: 2011-06-17 00:01:00
    MORE than 2,600 deaths in England from some of the most common types of cancer could be avoided each year if all cancer patients had the same chance of survival as the most affluent section of society, a new piece of research suggests.

  • Drop in pre-cancerous cervical changes in Australia after HPV vaccination introduced

    Updated: 2011-06-17 00:00:00
    The number of women with precancerous cervical changes has fallen in Victoria, Australia since the introduction of human papillomavirus (HPV) vaccination programmes, a new study has found.

  • Teenage BMI 'associated with future risk of cancer death in men'

    Updated: 2011-06-16 18:50:00
    Men who are overweight at age 18 may be more likely to die from cancer in later life than those who are a healthy weight in early adulthood, UK and US scientists have found.

  • Royal College of Surgeons report calls for greater investment in surgical research

    Updated: 2011-06-16 15:47:00
    Patient care could be jeopardised in the future unless the government takes steps to support surgical research, the Royal College of Surgeons (RCS) has warned.

  • AP's reasonable look at cancer scare stories

    Updated: 2011-06-16 15:00:09
    It is refreshing to see the Associated Press devote a little space to a little story, "Weighing cancer risks, from cellphones to coffee." Excerpt: "Despite all the recent news about possible cancer risks from cellphones, coffee, styrene and formaldehyde in building materials, most of us probably face little if any danger from these things with ordinary use, health experts say. Inactivity and obesity might pose a greater cancer risk than chemicals for some people."

  • Elderly breast cancer patients less likely to get surgery

    Updated: 2011-06-16 09:28:00
    Older women in the UK are less likely to have surgery for breast cancer than younger ones. And this difference can't be fully explained by age-related ill health from other diseases, according to new data presented today at the National Cancer Intelligence Network (NCIN) conference (Thursday).

  • CBS hypes "one of biggest medical advances since the scalpel"

    Updated: 2011-06-15 14:35:57
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org CBS hypes one of biggest medical advances since the scalpel By Gary Schwitzer on June 15, 2011 9:35 AM No Comments No TrackBacks A reader asked me to comment on a CBS News weekend story on high-intensity focused ultrasound After looking it up , I can now see why he asked . The hyperbole was off the charts : It may be one of the biggest medical advances since the scalpel huge breakthrough it's like a James Bond movie , you zap the target results are startling The results may have been startling in the one patient profiled , but , as we frequently remind readers , the plural of anecdote is not data . Yes , there are some good data on this approach for uterine fibroids .

  • Up to half of deaths in men from prostate cancer are directly due to the disease

    Updated: 2011-06-15 00:02:00
    Up to half the number of men with prostate cancer who die do so as a direct result of the disease, rather than from other causes according to a new study presented at the National Cancer Intelligence Network conference in London.

  • How do patients decide to accept implantable heart devices?

    Updated: 2011-06-14 16:59:53
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org How do patients decide to accept implantable heart devices By Gary Schwitzer on June 14, 2011 11:59 AM No Comments No TrackBacks Yesterday we posted a guest column that raised questions about whether reseachers overstate the benefits of implantable heart devices known as implantable cardioverter-defibrillators ICDs and cardiac resynchronization therapy CRT devices . Ultimately , that issue could influence the messages that patients receive . A paper in the journal Health Expectations Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death raises more questions about the messages patients receive

  • A call for a radical shift in physicians' prescribing attitudes and behaviors

    Updated: 2011-06-14 14:25:18
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org A call for a radical shift in physicians' prescribing attitudes and behaviors By Gary Schwitzer on June 14, 2011 9:25 AM No Comments No TrackBacks Researchers from Harvard and the University of Illinois at Chicago have published Principles of Conservative Prescribing in the Archives of Internal Medicine They write : The concept sums up lessons from past experience as well as from recent studies demonstrating that medications are commonly used inappropriately , overused , and associated with significant harm--suggesting the need to more thoughtfully weigh claims for drugs , especially new . drugs These principles urge clinicians to 1 think beyond drugs consider nondrug

  • Older women sidestep embarassing cervical smear tests

    Updated: 2011-06-14 00:01:00
    Older women are too embarrassed to go for smear tests, and fear pain, while younger women are too busy, according to a Cancer Research UK study, published in BJOG: An International Journal of Obstetrics and Gynaecology today.

  • Scientists reveal how collagen 'scaffolding' drives tumour growth

    Updated: 2011-06-13 17:00:00
    Cancer Research UK scientists have revealed how the dense tissue that surrounds tumours helps drive tumour growth and development, according to research published in the journal Cancer Cell.

  • Men's Health Week should improve decision-making aspects of its campaign

    Updated: 2011-06-13 15:12:46
    Gary Schwitzer's HealthNewsReview Blog Gary Schwitzer Publisher , HealthNewsReview.org feedback healthnewsreview.org Men's Health Week should improve decision-making aspects of its campaign By Gary Schwitzer on June 13, 2011 10:12 AM No Comments No TrackBacks This week has been proclaimed International Men's Health Week the week leading up to and including Father's Day . And it's part of what's more broadly been proclaimed by some as Men's Health Month The campaign offers a variety of men's health materials including the squeezy prostate stress ball pictured at left if you're into that kind of thing . There are also brochures like the one at right . The Facts About Prostate Cancer state that men at high risk should begin yearly screening at age 40 all others at age 50. The should begin at

  • Cancer Research Technology and Kurma Biofund to develop new antibody platform for translational research

    Updated: 2011-06-13 00:01:00
    Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.

  • Italian scientists reveal genetic root of rare form of leukaemia

    Updated: 2011-06-11 14:00:00
    Using cutting-edge DNA sequencing, Italian scientists have identified the underlying gene fault in a rare form of blood cancer called hairy-cell leukaemia (HCL), according to a paper published in the New England Journal of Medicine.

  • FDA Warns of High-Grade Prostate Ca Risk With BPH Drugs

    Updated: 2011-06-09 21:16:19
    WASHINGTON -- The FDA has issued a warning of an increased risk of high-grade prostate cancer with the 5-alpha reductase inhibitors finasteride (Proscar) and dutasteride (Avodart), currently approved to treat benign prostatic hypertrophy.

  • Three-year cervical screening is effective when HPV test and conventional examination are used together

    Updated: 2011-06-09 15:59:00
    Women who receive normal cervical screening results can safely attend screening just once every three years if both the human papillomavirus (HPV) test and conventional cytology test are used, a large new study has confirmed.

  • ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug

    Updated: 2011-06-09 15:08:56
    CHICAGO -- Two-thirds of men with castration-resistant prostate cancer (CRPC) had clinical benefit when treated with an investigational multitargeted tyrosine kinase inhibitor, data from a randomized trial showed.

  • Poorer women less likely to survive breast cancer

    Updated: 2011-06-09 00:01:00
    Poorer women from deprived areas are less likely to survive breast cancer as they are diagnosed at a later stage which means the best available treatments won't be as effective according to a new report out today (Thursday) by the National Cancer Intelligence Network (NCIN)

  • Manufacturers agree to lower cost of HPV vaccines in developing countries

    Updated: 2011-06-08 21:11:00
    A new commitment to lower the price of the human papillomavirus (HPV) vaccine for developing countries could help to prevent thousands of cases of cervical cancer in these nations.

  • Drug may reduce risk of developing breast cancer in high-risk women

    Updated: 2011-06-08 21:09:00
    A drug called exemestane (brand name Aromasin) significantly reduces the risk of breast cancer in healthy postmenopausal women who are at higher than average risk of developing the disease, according to research presented at a major US conference.

  • National bowel cancer audit shows continued progress

    Updated: 2011-06-08 16:36:00
    Bowel cancer care continues to improve in England and Wales, according to the latest annual report from the national audit of bowel cancer.

  • ASCO: Cell Count Predicts Prostate Ca Survival

    Updated: 2011-06-08 16:00:00
    CHICAGO -- Cells shed by a metastatic castration-resistant prostate cancer into the blood may be a robust measure of how well treatment is working, a researcher said here.

  • US trials show continued promise for two new skin cancer treatments

    Updated: 2011-06-08 15:29:00
    Two clinical trials presented at the largest annual cancer conference have raised hopes for new drugs designed to treat malignant melanoma, the most serious form of skin cancer.

  • Annual ovarian cancer screening fails to prevent deaths in US study

    Updated: 2011-06-07 01:40:00
    Annual screening for ovarian cancer with a blood test combined with an ultrasound scan did not reduce the risk of dying from the disease, but did increase the likelihood of invasive medical procedures, a US study has found.

  • Scientists identify genetic markers for common side-effect of taxane chemotherapy

    Updated: 2011-06-06 15:37:00
    US scientists have identified genetic markers associated with a common side-effect of taxane-based chemotherapy called peripheral neuropathy.

  • Gene fault could predict ovarian cancer drug success

    Updated: 2011-06-06 15:06:00
    Faults in a gene commonly inactivated in many different types of cancer could be used to predict which drug combination ovarian cancer patients are most likely to benefit from, according to results presented at the American Society for Clinical Oncology today.

  • Team at Cambridge MRC Cancer Cell Unit wins innovation prize

    Updated: 2011-06-06 12:39:00
    A team at the Medical Research Council (MRC) Cancer Cell Unit in Cambridge have won one of the Department of Health's first Innovation Challenge Prizes for their work on a new test for Barrett's oesophagus.

  • Cancer Research UK-funded scientists find way to eliminate leukaemia stem cells

    Updated: 2011-06-06 12:37:00
    Scientists at King's College London are working on a way of eliminating leukaemic 'stem cells' to prevent leukaemia from returning after a patient has received treatment.

  • Middle-aged survivors of childhood cancer at greater risk of certain cancers

    Updated: 2011-06-04 00:00:00
    CANCER RESEARCH UK scientists have found that survivors of childhood cancers are four times more likely than the general population to develop a new cancer. The results are published online today in JAMA.

  • FDA Finds No Link Between ARBs and Cancer

    Updated: 2011-06-02 23:51:36
    The use of angiotensin receptor blockers (ARBs) to lower blood pressure is not associated with an increased risk of developing cancer, the FDA announced after a formal safety review.

Current Feed Items | Previous Months Items

May 2011 | Apr 2011 | Mar 2011 | Feb 2011 | Jan 2011 | Dec 2010